Updates from the SCRC
Last chance to secure your tickets for SCRC annual symposium
Tickets are going quickly, and registration will close on the 9th June. A draft agenda and the final free tickets are now available.
We are also excited to announce our sponsors. Their support of this event keep tickets free for all, so please check them out below.
General Interest Events
Exhibition: PHARMAKON by Markus Taylor
Kick off our annual celebrations with a morning of creative cancer research engagement including presentations by:
- Deborah Humphrey and Karina Patfield: 'Words from the Waiting Room'
- Community Researchers on the Community Engagement Project for SCRC
- Markus Taylor, artists' presentation
- Lightning lectures from SCRC scientists
Lecture Theatre, Lower Ground Floor, Watson Building, Falmer, BN1 9PH Friday 13th June 2025 10:00AM
News
£566k Follow-on award secured for research into personalising cancer therapy
Dr Simon Mitchell has secured a three-year UK Research and Innovation Future Leaders Fellowship Renewal Award. His research combines computer modelling and lab experiments to personalise cancer treatment. During their Future Leaders Fellowship (FLF), Dr Mitchell’s team previously predicted which lymphoma patients might not respond to standard therapies. This new funding will test the approach in other cancers.
From our supporters
SARSTEDT
SARSTEDT, a family-run company, has been a leader in laboratory and medical technology for over six decades. A global team of more than 3,000 employees, we share a unified goal: to support laboratory professionals and medical practitioners. From development to production and sales, we ensure that our customers’ visions are implemented with precision and efficiency. We ensure the highest quality through standardised processes, constant monitoring and analysis. We also hold a deep commitment to the environment and future generations.
Apto-Gen
Apto-Gen is a technology-driven company dedicated to providing market-leading PCR and RT-qPCR enzymes and master mixes. Our mission is to improve DNA and RNA detection for more accurate diagnoses by bringing bespoke, high-quality molecular biology reagents to the healthcare and biotechnology markets.
Our Apto-Life product range has been developed for use in a broad range of life science applications, including high-performance RT-qPCR solutions for gene expression, genotyping and genetic studies, and high-fidelity DNA polymerases with enhanced processivity for cloning and sequencing applications.
Eppendorf
Eppendorf’s purpose to improve human living conditions is as old as the company itself and has lost none of its significance or power over the years. Our products, systems and services enable, improve, and facilitate research and routine work in laboratories all over the world. They inspire through innovation, quality, intelligence, performance, economic efficiency, ergonomics, and design. We are characterized by continuous investment in the innovation of our products, services, and business solutions, including through the involvement of partners and customers.
Qiagen
QIAGEN serves more than 500,000 customers globally, all seeking insights from DNA, RNA, and proteins. Using any biological sample, they are advancing science and improving outcomes for people everywhere. Our products for molecular testing serve applications from basic life sciences research to clinical healthcare. Together, we are making improvements in life possible.